Largest pharmaceutical companies in the United States by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at HUF 22.95T, ahead of Pfizer (HUF 22.03T) and Merck & Co (HUF 16.76T). Figures as of 20 Nov 2026, 22:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AbbVieHUF 22.95T
- Median
- HUF 778.5B
- Combined market value
- HUF 1270.21T
- Countries
- 1
- Not ranked
- 20no total debt on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | HUF 22.95T | HUF 172.02T | HUF 97,316.59 | 0.94% up | 20% up | ||
| 2 | PfizerPFE · Health Care | HUF 22.03T | HUF 53.1T | HUF 9,316.82 | 0.51% down | 10% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 16.76T | HUF 112.09T | HUF 45,468.81 | 0.69% up | 36% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | HUF 16.3T | HUF 221.4T | HUF 91,967.91 | 1.25% up | 31% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | HUF 15.34T | HUF 40.87T | HUF 19,993.76 | 0.79% up | 26% up | ||
| 6 | Eli LillyLLY · Health Care | HUF 14.45T | HUF 408.01T | HUF 458,057.81 | 0.30% down | 28% up | ||
| 7 | ViatrisVTRS · Health Care | HUF 4.9T | HUF 7.65T | HUF 6,674.79 | 1.26% down | 90% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | HUF 4.4T | HUF 60.66T | HUF 35,023.09 | 0.84% down | 19% down | ||
| 9 | ZoetisZTS · Health Care | HUF 3.07T | HUF 10.93T | HUF 26,899.77 | 2.08% down | 34% down | ||
| 10 | Royalty PharmaRPRX · Health Care | HUF 3.04T | HUF 13.38T | HUF 23,275.05 | 1.08% up | 74% up | ||
| 11 | Elanco Animal HealthELAN · Health Care | HUF 1.37T | HUF 4.37T | HUF 8,752.37 | 2.09% down | 18% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | HUF 874.5B | HUF 2.5T | HUF 7,181.43 | 1.26% down | 79% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | HUF 682.6B | HUF 5.04T | HUF 25,852.48 | 2.75% down | 15% up | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | HUF 675.3B | HUF 32.39T | HUF 313,062.22 | 0.19% down | 22% up | ||
| 15 | Ionis PharmaceuticalsIONS · Health Care | HUF 616.3B | HUF 1.51T | HUF 9,038.00 | 2.35% down | 64% down | ||
| 16 | InsmedINSM · Health Care | HUF 185.9B | HUF 10.54T | HUF 48,056.44 | 2.17% down | 27% down | ||
| 17 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 115.6B | HUF 2.99T | HUF 128,905.37 | 4.45% down | 28% down | ||
| 18 | Legend BiotechLEGN · Health Care | HUF 108.5B | HUF 1.01T | HUF 5,185.46 | 5.28% down | 43% down | ||
| 19 | CytokineticsCYTK · Health Care | HUF 97.8B | HUF 2.41T | HUF 17,266.72 | 1.32% down | 21% down | ||
| 20 | TG TherapeuticsTGTX · Health Care | HUF 83.5B | HUF 3.26T | HUF 21,537.50 | 2.37% down | 103% up | ||
| 21 | Cogent BiosciencesCOGT · Health Care | HUF 75.8B | HUF 1.58T | HUF 9,083.90 | 3.70% down | 25% down | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | HUF 63.8B | HUF 2.31T | HUF 43,986.28 | 4.66% down | 9% down | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 36.8B | HUF 2.65T | HUF 38,205.77 | 3.80% down | 15% up | ||
| 24 | Definium TherapeuticsDFTX · Health Care | HUF 13.8B | HUF 1.32T | HUF 9,636.45 | 3.87% down | 176% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 340.0 HUF). 20 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by total debt?
AbbVie (HUF 22.95T), Pfizer (HUF 22.03T) and Merck & Co (HUF 16.76T) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 20 Nov 2026, 22:11 UTC.
How many pharmaceutical companies in the United States are in this ranking?
24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of HUF 1270.21T as of 20 Nov 2026, 22:11 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.